Abstracts

AMC 054: Safety and Immunogenicity of the Quadrivalent HPV Vaccine in Indian HIV-Infected Women

Background: India has a high incidence of cervical cancer. HIV-infected Indian women may be at even higher risk than HIV-uninfected women. Quadrivalent HPV (qHPV) vaccination is effective in prevention of cervical cancer precursors due to HPV 6/11/16/18 in HIV-uninfected women. Little is known about safety and immunogenicity of qHPV in HIV-infected Indian women. Since the…

Regulatory B cells Attenuate Anti-HIV CTL Responses after Reactivation of Latent Reservoirs

Background: To achieve HIV eradication, the mechanisms underlying impaired cytotoxic T lymphocyte function (CTL) during antiretroviral therapy (ART) must be elucidated. In HIV-peptides stimulated samples, IL-10hi programmed-death ligand-1 (PD-L1)hi regulatory B cells (Bregs, CD19+CD24hiCD38hi) attenuate anti-HIV CTL activity. Here we investigate immunoregulatory Breg function in the clinically relevant setting of HIV viral reactivation in vitro…

Evaluation of HIV-1 Reservoir Characteristics in a Therapeutic HIV-1 Gag Vaccine Trial

Background: ACTG A5197 was a placebo-controlled trial of a therapeutic rAd5 HIV-1 gag vaccine in participants on suppressive antiretroviral therapy. The vaccine induced HIV-1 Gag-specific CD4+ interferon-γ-producing cells, which was correlated with lower viral rebound during an analytic treatment interruption (ATI). We investigated the effects of vaccination on HIV-1 reservoir characteristics prior to the ATI.…

Cross-Clade Inhibition of HIV on Primary Cells by CXCR4 or CCR5 Fused to the C34 Peptide from gp41 HR2

Background: HIV-1 entry into CD4+ T cells requires binding to CD4 and either the CCR5(R5)or CXCR4 (X4) co-receptor. Thus, strategies that disable productive co-receptor (CoR) engagement should provide potent protection from HIV infection. Previously we described a 34 amino acid peptide from the C-terminal heptad repeat-2 domain of gp41 (C34) which, when fused to the…

Engineered TCR-redirected Clearance of Gag-positive Reservoir Cells from ART-treated Subjects

Background: Combination ART is unable to eradicate HIV infection due to rapid establishment of a reservoir of long-lived latently infected CD4+ T cells. Immunotherapeutic strategies that target viral reservoirs are needed to achieve a functional cure. Immune-mobilising monoclonal T cell receptors (TCRs) have been used successfully to kill cancer cells without the need for ex…

Maraviroc reverts latent HIV-1 in ART suppressed patients through NFkB without viral load increase

Background: CCR5 intracellular signaling pathways leading to NF-κB, NFAT and AP-1 activation, could promote HIV-1 transcription in resting CD4+ T cells. In previous experiments, we have shown that maraviroc could activate NF-κB and specific target genes in resting CD4+ T cells from viremic and ART suppressed HIV-1 infected patients. The aim of the current work…

TNF Drives Foam Cell Formation by Monocytes from HIV+ Donors in an In Vitro Atherosclerosis Model

Background: HIV+ individuals have an increased risk of cardiovascular disease (CVD) which is independent of traditional risk factors, but the mechanisms driving this are unknown. We have recently shown that monocytes are activated in HIV+ patients despite combination antiretroviral therapy, and that this is associated with chronic inflammation. The migration of monocytes across endothelial blood…

Exposure To IFNα Leads To Generation of IL-10-Producing Tr1 Cells

Background: In HIV-1 infection elevated serum levels of interferon alpha (IFNα) and Interleukin-10 (IL-10) are associated with immune hyperactivation and disease progression. Recently, coexpression of CD49b and LAG-3 was shown to identify Type 1 regulatory cells, which secrete large amounts of the immunesuppressive cytokine IL-10. This study aimed at assessing whether IFNα production during HIV…